-
1
-
-
20144363192
-
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
-
1:CAS:528:DC%2BD2MXisFGrs7g%3D 15781101
-
EJ Baxter LM Scott PJ Campbell C East N Fourouclas S Swanton, et al. 2005 Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders Lancet 365 1054 1061 1:CAS:528:DC%2BD2MXisFGrs7g%3D 15781101
-
(2005)
Lancet
, vol.365
, pp. 1054-1061
-
-
Baxter, E.J.1
Scott, L.M.2
Campbell, P.J.3
East, C.4
Fourouclas, N.5
Swanton, S.6
-
2
-
-
20244369569
-
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
-
DOI 10.1016/j.ccr.2005.03.023
-
RL Levine M Wadleigh J Cools BL Ebert G Wernig BJ Huntly, et al. 2005 Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis Cancer Cell 7 387 397 10.1016/j.ccr.2005.03.023 1:CAS:528:DC%2BD2MXjvFSku7o%3D 15837627 (Pubitemid 40544655)
-
(2005)
Cancer Cell
, vol.7
, Issue.4
, pp. 387-397
-
-
Levine, R.L.1
Wadleigh, M.2
Cools, J.3
Ebert, B.L.4
Wernig, G.5
Huntly, B.J.P.6
Boggon, T.J.7
Wlodarska, I.8
Clark, J.J.9
Moore, S.10
Adelsperger, J.11
Koo, S.12
Lee, J.C.13
Gabriel, S.14
Mercher, T.15
D'Andrea, A.16
Frohling, S.17
Dohner, K.18
Marynen, P.19
Vandenberghe, P.20
Mesa, R.A.21
Tefferi, A.22
Griffin, J.D.23
Eck, M.J.24
Sellers, W.R.25
Meyerson, M.26
Golub, T.R.27
Lee, S.J.28
Gilliland, D.G.29
more..
-
3
-
-
33846660947
-
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis
-
DOI 10.1056/NEJMoa065202
-
LM Scott W Tong RL Levine MA Scott PA Beer MR Stratton, et al. 2007 JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis N Engl J Med 356 459 468 10.1056/NEJMoa065202 1:CAS:528:DC%2BD2sXht1ersrc%3D 17267906 (Pubitemid 46193073)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.5
, pp. 459-468
-
-
Scott, L.M.1
Tong, W.2
Levine, R.L.3
Scott, M.A.4
Beer, P.A.5
Stratton, M.R.6
Futreal, P.A.7
Erber, W.N.8
McMullin, M.F.9
Harrison, C.N.10
Warren, A.J.11
Gilliland, D.G.12
Lodish, H.F.13
Green, A.R.14
-
4
-
-
34748868427
-
Insights into JAK2-V617F mutation in CML
-
DOI 10.1016/S1470-2045(07)70295-4, PII S1470204507702954
-
M Bocchia AM Vannucchi A Gozzetti P Guglielmelli G Poli R Crupi, et al. 2007 Insights into JAK2-V617F mutation in CML Lancet Oncol 8 864 866 10.1016/S1470-2045(07)70295-4 1:CAS:528:DC%2BD2sXhtFektb%2FE 17913657 (Pubitemid 47488062)
-
(2007)
Lancet Oncology
, vol.8
, Issue.10
, pp. 864-866
-
-
Bocchia, M.1
Vannucchi, A.M.2
Gozzetti, A.3
Guglielmelli, P.4
Poli, G.5
Crupi, R.6
Defina, M.7
Bosi, A.8
Francesco, L.9
-
5
-
-
34447639429
-
Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis [4]
-
DOI 10.1038/sj.leu.2404730, PII 2404730
-
M Bornhauser B Mohr U Oelschlaegel P Bornhauser S Jacki G Ehninger, et al. 2007 Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis Leukemia 21 1824 1826 10.1038/sj.leu.2404730 1:STN:280:DC%2BD2svhs1Wnsw%3D%3D 17476275 (Pubitemid 47086774)
-
(2007)
Leukemia
, vol.21
, Issue.8
, pp. 1824-1826
-
-
Bornhauser, M.1
Mohr, B.2
Oelschlaegel, U.3
Bornhauser, P.4
Jacki, S.5
Ehninger, G.6
Thiede, C.7
-
6
-
-
56649102281
-
Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia
-
10.1007/s12185-008-0131-2 18626727
-
MR Conchon JL Costa MM Novaes PE Dorlhiac-Llacer D de Alencar Fischer Chamone I Bendit 2008 Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia Int J Hematol 88 243 245 10.1007/s12185-008-0131-2 18626727
-
(2008)
Int J Hematol
, vol.88
, pp. 243-245
-
-
Conchon, M.R.1
Costa, J.L.2
Novaes, M.M.3
Dorlhiac-Llacer, P.E.4
De Alencar Fischer Chamone, D.5
Bendit, I.6
-
7
-
-
65649152398
-
BCR-ABL positive chronic myeloid leukemia with concurrent JAK2(V617F) positive myelodysplastic syndrome/myeloproliferative neoplasm (RARS-T)
-
10.1002/ajh.21296 18951468
-
S Gattenlohner HU Volker B Etschmann H Einsele HK Muller-Hermelink 2009 BCR-ABL positive chronic myeloid leukemia with concurrent JAK2(V617F) positive myelodysplastic syndrome/myeloproliferative neoplasm (RARS-T) Am J Hematol 84 306 307 10.1002/ajh.21296 18951468
-
(2009)
Am J Hematol
, vol.84
, pp. 306-307
-
-
Gattenlohner, S.1
Volker, H.U.2
Etschmann, B.3
Einsele, H.4
Muller-Hermelink, H.K.5
-
8
-
-
34247397427
-
Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation
-
10.1182/blood-2006-12-061135 1:CAS:528:DC%2BD2sXkvFChsro%3D 17449802
-
K Hussein O Bock A Seegers M Flasshove F Henneke G Buesche, et al. 2007 Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation Blood 109 4106 4107 10.1182/blood-2006-12-061135 1:CAS:528:DC%2BD2sXkvFChsro%3D 17449802
-
(2007)
Blood
, vol.109
, pp. 4106-4107
-
-
Hussein, K.1
Bock, O.2
Seegers, A.3
Flasshove, M.4
Henneke, F.5
Buesche, G.6
-
9
-
-
34548138920
-
V617F mutation' by Dr Ronald S Go [6]
-
DOI 10.1038/sj.leu.2404826, PII 2404826
-
M Inami K Inokuchi M Okabe F Kosaka Y Mitamura H Yamaguchi, et al. 2007 Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemia Leukemia 21 1103 1104 10.1038/sj.leu.2404826 1:CAS:528:DC%2BD2sXksFeltrk%3D 17301812 (Pubitemid 47299984)
-
(2007)
Leukemia
, vol.21
, Issue.9
, pp. 2052
-
-
Inami, M.1
Inokuchi, K.2
Yamaguchi, H.3
Dan, K.4
-
10
-
-
44749088675
-
Emergence of therapy-unrelated CML on a background of BCR-ABL-negative JAK2V617F-positive chronic idiopathic myelofibrosis
-
10.1016/j.leukres.2008.03.004 1:CAS:528:DC%2BD1cXntlGgs7Y%3D 18448166
-
L Jallades S Hayette I Tigaud A Johnston B Coiffier JP Magaud, et al. 2008 Emergence of therapy-unrelated CML on a background of BCR-ABL-negative JAK2V617F-positive chronic idiopathic myelofibrosis Leuk Res 32 1608 1610 10.1016/j.leukres.2008.03.004 1:CAS:528:DC%2BD1cXntlGgs7Y%3D 18448166
-
(2008)
Leuk Res
, vol.32
, pp. 1608-1610
-
-
Jallades, L.1
Hayette, S.2
Tigaud, I.3
Johnston, A.4
Coiffier, B.5
Magaud, J.P.6
-
11
-
-
34347204845
-
JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia
-
DOI 10.1016/S1470-2045(07)70206-1, PII S1470204507702061
-
A Kramer A Reiter J Kruth P Erben A Hochhaus M Muller, et al. 2007 JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia Lancet Oncol 8 658 660 10.1016/S1470-2045(07)70206-1 17613428 (Pubitemid 46995638)
-
(2007)
Lancet Oncology
, vol.8
, Issue.7
, pp. 658-660
-
-
Kramer, A.1
Reiter, A.2
Kruth, J.3
Erben, P.4
Hochhaus, A.5
Muller, M.6
Cross, N.C.7
Jones, A.V.8
Ho, A.D.9
Hensel, M.10
-
12
-
-
41949128334
-
Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders
-
10.1182/blood-2007-06-095703 1:CAS:528:DC%2BD1cXivFaktbc%3D 18006699
-
A Pardanani BL Fridley TL Lasho DG Gilliland A Tefferi 2008 Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders Blood 111 2785 2789 10.1182/blood-2007-06-095703 1:CAS:528:DC%2BD1cXivFaktbc%3D 18006699
-
(2008)
Blood
, vol.111
, pp. 2785-2789
-
-
Pardanani, A.1
Fridley, B.L.2
Lasho, T.L.3
Gilliland, D.G.4
Tefferi, A.5
|